(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

DENDREON TARGETING CANCER, TRANSFORMING LIVES

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

DENDREON TARGETING CANCER, TRANSFORMING LIVES

ST13

US500000090243305

Class

5

Filing

90243305

Registration

6408192

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

20

Latest update

07/06/2026

Trademark type

Combined

Nice classes

5

Filing date

10/08/2020

Registration date

07/06/2021

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

07/06/2021

Last transaction

07/06/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

First use anywhere

04/29/2010

First use in commerce

04/29/2010

Drawing code

3

Owner type

16

Owner location

Seal Beach, CA, US

Examiner

HOWARD, PARKER WALDRIP

Law office

M80

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the term "Dendreon" having a capital "D" and lowercase "endreon" in combination with a design element, the design element consisting of two discrete parts located above the adjacent letters "e," "o," and "n," the first part being a feather shape having two pointed ends, the upper side of which is formed by a convex arc, and the lower side of which is formed by an elongated sine wave shape, resulting in the left side of the feather being thin and quill-shaped, and the right side of the feather being wider and rounder, the whole of the feather-shaped first part extending from the left side of the "e" slightly upward to the right side of the "o"; and the second part of the design element consisting of the x-axis mirror image of the first part, located to its right, such that the upper side of the feather-shaped second part is formed by an elongated cosine wave shape and the lower side is formed by a concave arc, with the whole of the feather-shaped second part extending from the left side of the "o" slightly upward to the right side of the "n," resulting in the right half of the feather-shaped first part overlapping with the left half of the feather-shaped second part; and a tag line portion below the term "Dendreon" consisting of the phrase "Targeting Cancer, Transforming Lives" in title case.

Holders and representatives

Holders

Dendreon Pharmaceuticals LLC

Representatives

Diane L. Gardner MASTERMIND IP LAW P.C.

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Antibacterial pharmaceuticals; Antibacterial substances for medical purposes; Cells for medical or clinical use; Chemical preparations for pharmaceutical or medical purposesfor cancerinfectious diseasesautoimmune diseasesallergiesgenetically induced conditions; Intravenous bags sold filled with sipuleucel-T; Pharmaceutical preparations for the treatment and prevention of cancerinfectious diseasesautoimmune diseasesallergiesgenetically induced conditions; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of cancerinfectious diseasesautoimmune diseasesallergiesgenetically induced conditions; Pharmaceutical preparations for cancerinfectious diseasesautoimmune diseasesallergiesgenetically induced conditions; Pharmaceutical preparationsantivirals; Pharmaceutical products for the treatment of cancer; Pharmaceuticalsanti-infectives; Therapeutic pharmaceutical for the treatment of cancerinfectious diseasesautoimmune diseasesallergiesgenetically induced conditions; Living cells for medical use; Pharmaceutical preparations for the treatment of infectious diseases

Publications

History of USPTO decisions and trademark events.

20 publications found

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

07/06/2026

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

12/04/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

12/04/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

12/04/2024

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

12/04/2024

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

12/04/2024

WOAG

WITHDRAWAL OF ATTORNEY GRANTED

12/04/2024

WOAR

TEAS WITHDRAWAL OF ATTORNEY RECEIVED

12/04/2024

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

04/20/2023

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

04/20/2023

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

04/20/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

07/06/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

04/20/2021

PUBO

PUBLISHED FOR OPPOSITION

04/20/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

03/31/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/12/2021

DOCK

ASSIGNED TO EXAMINER

03/08/2021

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

11/25/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

11/24/2020

NWAP

NEW APPLICATION ENTERED

10/12/2020

Continuous trademark protection

Get notified about every new filing that threatens DENDREON TARGETING CANCER, TRANSFORMING LIVES or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.